Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ORMDL Proteins Turnover via Proteasome and Autophagy Is Cell-Type Dependent and Tied to Ceramide Homeostasis. | FASEB J | 2026 | 41806112 | PubTator, text mining | PubMed |
| The Yin-Yang balance of SIRT1 and SIRT2 in cancer metabolic remodeling. | Int J Biol Sci | 2026 | 41800243 | PubTator, text mining | PubMed |
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
| Laryngeal squamous cell carcinoma: a functional "two-hit" model of papillomavirus-Epstein-Barr virus synergistic carcinogenesis. | Front Cell Infect Microbiol | 2026 | 41798741 | PubTator, text mining | PubMed |
| [Risk predication for metastasis and grading system in complex adrenal pheochromocytoma and paraganglioma]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41795990 | PubTator, text mining | PubMed |
| Exploring the role of microRNA-155 as a biomarker and regulatory modulator of target genes in metabolic syndrome. | SAGE Open Med | 2026 | 41777416 | PubTator, text mining | PubMed |
| Comparative GWAS using global and Indian Reference Panels reveals non-coding drivers of COVID-19 severity and mortality. | PLoS Negl Trop Dis | 2026 | 41774713 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognostic Significance of NPAS1 in Patients with Colorectal Adenocarcinoma Based on Bioinformatics. | Int J Gen Med | 2026 | 41773256 | PubTator, text mining | PubMed |
| The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption? | Transl Oncol | 2026 | 41764979 | PubTator, text mining | PubMed |
| Disruption of neutrophil homeostasis is associated with functional alterations in mitochondria of critically ill COVID-19 patients. | Sci Rep | 2026 | 41764210 | PubTator, text mining | PubMed |
| In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases. | Hum Mutat | 2026 | 41756679 | PubTator, text mining | PubMed |
| Yizong Tongluo formula attenuates idiopathic pulmonary fibrosis and inflammatory injury by inhibiting HIF-1α/LSH/SCD1-mediated ferroptosis. | Front Immunol | 2026 | 41756284 | PubTator, text mining | PubMed |
| Hypoxia Preserves Chromatin Integrity and Delays Cellular Senescence through Epigenetic Regulation. | Biomol Ther (Seoul) | 2026 | 41755769 | PubTator, text mining | PubMed |
| Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments. | Int J Mol Sci | 2026 | 41751791 | PubTator, text mining | PubMed |
| Whole-Blood Expression of Candidate Genes Linked with Pheochromocytoma in Post-Surgery Patients: A Pilot Study. | Biomedicines | 2026 | 41751294 | PubTator, text mining | PubMed |
| Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects. | Antioxidants (Basel) | 2026 | 41750534 | PubTator, text mining | PubMed |
| Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance. | Cancer Pathog Ther | 2026 | 41732210 | PubTator, text mining | PubMed |
| Transcriptomic Insights into lncRNA-miRNA-mRNA Networks Regulating Angiogenesis and Metastasis in Prostate Cancer. | BioTech (Basel) | 2026 | 41718350 | PubTator, text mining | PubMed |
| Branched-chain amino acid transaminases as promising targets in tumor therapy. | Front Cell Dev Biol | 2026 | 41716286 | PubTator, text mining | PubMed |
| From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in Paragangliomas. | Endocr Pathol | 2026 | 41706251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=3